The Atlanta-based startup Clearside Biomedical plans to develop microinjection technology invented by the labs of researchers Mark Prausnitz of Georgia Tech and Emory Professor of Ophthalmology Henry Edelhauser that uses hollow microneedles to precisely target therapeutics to the back of the eye to treat diseases such as age-related macular degeneration.